Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Travel Through 25 Years with Us, Share Your Most Authentic Story with Maxin!

The number 5 is a magical number for Chinese people. Our ancestors, using their wisdom, always skillfully connected everything closely ...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Striving for Excellence and Approaching Perfection, Maixin Achieves Outstanding Results Again in the NordiQC 2019 Interlaboratory Quality Assessment.

Editor's Note:NordiQC, the Nordic Immunohistochemistry Quality Control Center, is one of the internationally authoritative inter-labora...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Renegotiation Announcement for Production and Laboratory Equipment Procurement Project of Fuzhou Maixin Biotechnology Development Co., Ltd. (Second Round)

Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Maixin Biotech Holds Business Etiquette Internal Training

To enhance the overall quality of employees and establish a good corporate image for the company, on March 1, 2008, Maixin Company invi...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

China National Pharmaceutical Group Vice President Hu Jianwei Visits Maxin Biotech for Research and Inspection

Introduction:On the morning of March 14, 2023, Hu Jianwei, Vice President of Sinopharm Group (in charge of operations), and Vice Presid...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

On the Road – The Treasure Island of Taiwan (Part Two)

        On the Road - Kenting, the Treasure Island of TaiwanAfter enjoying a breakfast with distinct Taiwanese char...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Striving to Lead Amidst Competition; Persevering with Diligence for Long-term Success — Maixin Company Successfully Holds 2020 Annual Work Summary Meeting

Introduction:Looking back on 2020, it was destined to be an extraordinary year. The sudden outbreak of the pandemic shattered the tranq...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

We sincerely wish you a happy National Day!

RaisetheNationin CelebrationJoyfully Welcome National DayFortunate, only because we are born Chinese;Proud, only because we have a stro...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

MaiXin’s Self-Developed Novel Liver Cancer Detection Kit, in Collaboration with Academician Wang Hongyang’s Team, Receives First CFDA Certification.

In August 2014, Fuzhou Maixin Biotechnology Development Co., Ltd. (hereinafter referred to as "Maixin Company") collaborated with Acade...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

On my 25th birthday, we are grateful for your blessings.

At twenty-five, for Maxin, it is a declaration of maturity and a brand new beginning.We are very grateful to the pathology teachers for...
Continue reading
  • «
  • ‹
  • 7
  • 8
  • 9
  • 10
  • 11
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar